Top Markets
#1 MowCat MowCat +48.45%
#2 Bermuda Shorts Bermuda Shorts +31.49%
#3 Biconomy Biconomy +22.77%
#4 Velvet Velvet +21.04%
#5 Derive Derive +17.92%
#6 MarsCoin MarsCoin +17.75%
#7 Quack AI Quack AI +17.33%
#8 Audiera Audiera +14.23%
#9 Perle Perle +14.15%
#10 aPriori aPriori +13.82%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
Medigene AG Medigene AG

Medigene AG

MDG1
株式のランク #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
株価
$0.14942078
最終同期: 2025-05-15
時価総額
$3.86M
変化（1日）
0.10%
変化（1年）
0.00%
国
DE
取引 Medigene AG (MDG1)

カテゴリー

Healthcare
Medigene AG（MDG1）の発行済株式数
June 2024 時点の発行済株式数 12.93M
Medigene AG の最新の財務報告および株価によると、現在の発行済株式数は 12.93M です。December 2022 の終わりには、同社は 12.93M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Medigene AG（MDG1）の発行済株式数の履歴（2004 ～ 2026）
各年末時点の発行済株式数
年 発行済株式数 変化
2026 (TTM) 12.93M 5.30%
2023 12.28M -5.04%
2022 12.93M 0.00%
2021 12.93M 0.00%
2020 12.93M 0.01%
2019 12.93M -48.12%
2018 24.93M 10.08%
2017 22.64M 7.76%
2016 21.01M 25.00%
2015 16.81M 37.65%
2014 12.21M 27.07%
2013 9.61M 3.65%
2012 9.27M 89.92%
2011 4.88M 1.42%
2010 4.81M 6.81%
2009 4.51M 0.66%
2008 4.48M 7.82%
2007 4.15M 40.74%
2006 2.95M 20.75%
2005 2.44M 32.61%
2004 1.84M 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数 差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 1,863.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 380.84%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE